Charles River Laboratories Announces Second-Quarter 2026 Results
Revenue$1.00 billion−2.7% YoY
Adj. EPS$3.02−3.2% YoY
Outlookrevisedguidance
Collected automatically from companies' SEC filings (Form 8-K, Item 2.02)
Forensic equity research on US stocks. No spam, unsubscribe anytime.